Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs

Clinical Infectious Diseases

Volumn 61, Issue 7, 2015, Pages 1141-1143

  Grayson, M Lindsay ^a,b   Macesic, Nenad ^a   Trevillyan, Janine ^a,c   Ellis, Andrew G ^b,d   Zeglinski, Phillip T ^b   Hewitt, Nicholas H ^a   Gardiner, Bradley J ^a   Frauman, Albert G ^b,d  

^a Austin Health   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ALFRED HEALTH   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

fosfomycin; microbial drug resistance; pharmacology; prostatitis

Indexed keywords

CIPROFLOXACIN; ERTAPENEM; FOSFOMYCIN; LOPERAMIDE; MEROPENEM; PENICILLINASE; PROSTATE SPECIFIC ANTIGEN; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DEFECATION URGENCY; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ESCHERICHIA COLI; HUMAN; KINETICS; MALE; MINIMUM INHIBITORY CONCENTRATION; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATITIS; STEADY STATE; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT INFECTION; URINE CULTURE; BLOOD; MULTIDRUG RESISTANCE; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FOSFOMYCIN; HUMANS; MALE; PROSTATITIS; URINARY TRACT INFECTIONS;

EID: 84942154691     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ436     Document Type: Article

References (14)

1. Cunha BA, Gran A, Raza M. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline. Int J Antimicrob Agents 2015; 45:427-9
2. Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy 2003; 49:269-79
3. Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis 2010; 50:1641-52
4. Liss MA, Johnson JR, Porter SB, et al. Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis 2015; 60:979-87
5. Batura D. Editorial commentary: fluoroquinolone-resistant intestinal organisms and infections after prostate biopsy: shifting sands of the prevention narrative. Clin Infect Dis 2015; 60:988-9
6. Gardiner BJ, Mahony AA, Ellis AG, et al. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis 2014; 58:e101-5
7. Takasaki N, Ra S, Okada S, et al. Transference of antibiotics into prostatitic tissues: sampling method by transurethral resection for the measurement of concentration of antibiotics in the prostatic tissues [in Japanese]. Hinyokika Kiyo 1986; 32:969-75
8. Hagiya H, Ninagawa M, Hasegawa K, et al. Fosfomycin for the treatment of prostate infection. Intern Med 2014; 53:2643-6
9. Peirano G, Ahmed-Bentley J, Woodford N, Pitout JD. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis 2011; 17:242-4
10. Guerin F, Henegar C, Spiridon G, Launay O, Salmon-Ceron D, Poyart C. Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia. J Antimicrob Chemother 2005; 56:601-2
11. Shrestha NK, Amuh D, Goldman MP, Riebel WJ, Tomford WJ. Treatment of a complicated vancomycin-resistant enterococcal urinary tract infection with fosfomycin. Infect Dis Clin Pract 2000; 9:368-71
12. Rhodes NJ, Gardiner BJ, Neely MN, et al. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis. J Antimicrob Chemother 2015; 70:2068-73
13. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103-20
14. Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 2013; 57:267-74